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  ABSTRACT 
 
Premature neonates supported by invasive mechanical ventilation (IMV) are at 
increased risk of necrotizing enterocolitis (NEC). NEC is characterized by disruption to 
the immature intestinal barrier and enterocyte damage. We previously showed that 
preterm lambs managed by IMV for 21 days have feeding intolerance, poor weight gain 
and injury to the distal ileum that resembles NEC. In contrast, preterm lambs managed by 
non-invasive support (NIS) for 21 days tolerate feedings, have better postnatal growth 
and better gut histology. The distinct outcomes of preterm lambs managed by IMV and 
NIS provide an opportunity to evaluate the impact of variables associated with IMV, such 
as poor postnatal nutrition and sedation, on gut integrity. Using the positive outcome 
group NIS, preterm lambs received restricted enteral intake (NIS+RN), or sedation 
(NIS+ES) at levels matched to that of IMV-managed preterm lambs. 
The transcription factor PPARγ is required for gut integrity. Transcriptional 
targets of PPARγ, also important for gut barrier integrity, are FABP2 and the tight 
junction protein occludin. We hypothesize that in preterm lambs, IMV, NIS+RN and 
NIS+ES reduce gut integrity in association with decreased ileal expression of PPARγ, 
FABP2 and occludin. 
To test our hypothesis, we studied six groups of preterm lambs: IMV or NIS for 3 
or 21 days, and NIS+RN and NIS+ES for 21 days. A reference group was unventilated 
term lambs. Expression of PPARγ, FABP2 and occludin was measured in ileal tissue. 
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Preterm lambs managed by IMV and NIS+RN, had impaired postnatal growth and 
reduced expression of PPARγ and FABP2 compared to preterm lambs managed by NIS. 
Preterm lambs managed by NIS+ES did not have feeding intolerance or poor postnatal 
growth, but did have reduced PPARγ and FABP2 expression compared to preterm lambs 
managed by NIS. Contrary to our hypothesis, occludin protein abundance was not 
impacted by mode of ventilation, nutrition or sedation. 
In conclusion, IMV, NIS+RN and NIS-ES decreased PPARγ and FABP2 
expression in the preterm lamb ileum. Disruption of PPARγ and FABP2 expression by 
IMV and inadequate nutrition may result in detrimental effects on gut integrity and 
contribute to the observed NEC-like phenotype in preterm lambs.  
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 Necrotizing enterocolitis (NEC), a severe gastrointestinal disease, is one of the 
most common life-threatening diseases affecting neonates1, 2. The majority of NEC cases 
occur in premature infants less than 37 weeks gestation, with a mortality rate of 20-50%2. 
Typical onset of NEC is in the first three months of life after feeding intolerances are 
observed2. There are three stages of NEC in the Bell’s diagnosis criteria. In stage I and II 
NEC, symptoms include abdominal distention, bloody stool, absent bowel sounds and 
ascites2, 3. In more advance Bell’s stage III NEC, bacterial translocation, multiple dilated 
loops of the small bowel, gas-filled loops, bowel perforation and septic shock occur2, 3. 
About one third of NEC cases require surgery3.  Long-term consequences of NEC include 
prolonged hospitalization, short bowel syndrome, parenteral nutrition-associated 
cholestasis, significantly impaired growth and poor long-term neurodevelopment4.  
 Despite ongoing research, the pathogenesis, prevention and treatment of NEC is 
not completely understood. The main factors thought to be involved in the development 
of NEC are prematurity, ischemic injury, early formula feeding, dysbiosis, intestinal 
permeability and inflammatory responses1, 2. One component of NEC is damage to the 
enterocytes that comprise the intestinal epithelium, and subsequent loss of integrity of the 
intestinal barrier. Damage and loss of integrity of the intestinal epithelium in NEC (see 
Figure 1) is severe and results in in increased gut permeability and bacterial translocation.
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Prematurity further compromises the gastrointestinal integrity. Prematurity is marked by 
immaturity of gut motility and intestinal epithelial cells, increasing the amount of bacteria 
within the gut and reducing the gut’s ability to protect against bacterial translocation2. 
Intestinal permeability further increases the potential for bacteria to translocate, leading 
to systemic inflammatory responses1, 2. 
 
Respiratory Support and NEC 
While risk factors for NEC are many, one important risk factor for NEC in 
preterm infants is invasive mechanical ventilation (IMV). Preterm neonates frequently 
require IMV for respiratory support secondary to immature lung development. In IMV, 
an endotracheal tube is placed to facilitate ventilation. Infants with IMV require greater 
sedation and analgesics to minimize discomfort and stress7, 8. Infants who required IMV 
during their neonatal ICU course are approximately 13 times more likely to develop NEC 
than preterm infants who do not require IMV4. Furthermore, inflammation that 
accompanies NEC increases metabolic demands, causing respiratory decompensation and 
an increased need for mechanical ventilation9. While we know there is a link between 
prematurity, IMV and NEC, the molecular mechanisms that give rise to NEC are not 
completely understood.  
 
Signaling Pathways Important for Gut Integrity 
 Peroxisome proliferator-activated receptor gamma (PPARγ) is a nutrient sensitive 
nuclear receptor that modulates gene transcription. PPARγ is expressed in a number of 
tissues, including the epithelium of the small and large intestines. In animal models, 
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pretreatment with a PPARγ agonist has been shown to protect against NEC-like injuries 
to enterocytes10, 11, 12. One way that agonists of PPARγ ameliorate gastrointestinal injury 
is by promoting and stabilizing epithelial differentiation13.  
Activation of PPARγ, in the intestines, is reliant on intestinal fatty acid binding 
protein or FABP2. FABP2 has a high affinity for binding long-chain saturated and 
unsaturated fatty acids14. The role of FABP2 is to transport long chain fatty acids from 
the cytosol into the nucleus of the enterocyte. They can then act as ligands for PPARγ, 
thus enhancing transcriptional activity15.  
Transcriptional target genes of PPARγ include those important for enterocyte 
development and the intestinal barrier, including FABP2 itself. FABP2 is located in the 
cytosol of the tips of microvilli and only expressed by mature enterocytes16. Animal and 
human studies have shown that upon mucosal damage, enterocytes release FABP2 into 
circulation10, 16, 17, 18, 19. Intestinal FABP may be a useful plasma and urinary marker for 
enterocyte integrity and development of NEC16, 18, 19, 20. There is a positive association 
between circulating FABP2 concentrations and severity of NEC2, 19, 20. Interestingly, 
pretreatment with either fish oil or PPARγ agonist 15d-PGJ2 reduces the redistribution of 
FABP2 from mucosa into the circulation following induced ischemia and reperfusion in 
the rat10. This suggests a protective relationship between PPARγ and FABP2.  
One mechanism by which PPARγ and FABP2 may confer gut protection is via 
maintenance of tight junctions and reduced gut permeability. Preterm infants diagnosed 
with NEC have decreased tight junction barrier function and decreased expression of the 
protein occludin21. Occludin’s role in tight junctions is to regulate epithelial barrier 
function21, 22. Occludin is also required for cells to transduce cytokine-mediated signals 
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that either increase the epithelial barrier or decrease the large solute barrier22. Without 
occludin, there is a complete loss of tight junction barrier function that results in elevated 
permeability, mucosal injury and inflammation. Active PPARγ can bind to the promoter 
region of the occludin gene, directly raising occludin expression21. A pretreatment of 
either PPARγ agonist, 15d-PGJ2 or fish oil, has been shown to protect the morphology of 
tight junctions and occludin expression in the rat10. Permeability is an important 
predisposing factor involved in the development of NEC in humans, therefore modulation 
of barrier function could impact NEC outcomes in preterm infants.  
 
Preliminary Data 
Our lamb model is designed to examine the mechanisms of preterm birth and 
chronic ventilation on disease development. Our lamb model of preterm birth is unique, 
follows neonatal intensive care unit protocols and is clinically relevant.  Clinical 
relevance of our model is further enhanced by the developmental biology of the lamb gut 
closely resembling that of human neonates17. Details of the lamb model are further 
discussed in Methods. 
Our preliminary data show mode of ventilation affects disease outcomes in 
preterm lambs.  Our lab showed preterm lambs managed by IMV for 21 days have 
feeding intolerance, poor weight gain and significant injury to the distal ileum that 
resembles NEC23,24 (see Table 1, Figure 2 and 3). In contrast, preterm lambs managed by 
non-invasive support (NIS) for 21 days tolerate feedings that led to larger enteral intake, 
better postnatal growth and better gut histology24. Morphometric analysis of gut histology 
shows that in preterm lambs managed by IMV, villus length and crypt depth is decreased 
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both at 3 days and 21 days compared to gestationally matched, preterm NIS lambs.  
Apoptosis, programmed cell death, is a regulated process that ensures gut integrity. 
Apoptosis was significantly reduced in the ileum of preterm lambs managed by IMV 
compared to preterm lambs managed by NIS. These data suggest IMV preterm lambs 
experience gut necrosis. Lastly, within the IMV group of preterm lambs, two lambs had 
damage severe enough to meet the criteria of stage III NEC diagnosis25.  
The distinct outcomes of preterm lambs managed by IMV and NIS provide an 
opportunity to evaluate the impact of different variables associated with IMV and NIS, 
such as poor postnatal nutrition and growth, and sedation on gut integrity. Our lab has 
previously examined the effect of isolated postnatal nutrition and poor growth, and 
isolated sedation on alveolar formation26. We used the positive outcome mode of 
ventilation, NIS and manipulated both postnatal nutrition and sedation. As previously 
mentioned, preterm lambs managed by IMV for 21 days have feeding intolerance and 
poor growth relative to preterm lambs managed by NIS.  Additionally, preterm lambs 
managed by IMV require sedation, whereas preterm lambs managed by NIS do not. 
Therefore, we used preterm lambs managed by NIS with restricted nutrition (NIS+RN 
group) or standard nutrition (NIS control group) to assess the isolated contribution of 
restricted nutrition to gut integrity. The NIS+RN group was defined as preterm lambs 
managed by NIS with nutrient intake restricted to that tolerated by IMV lambs.  A group 
of preterm lambs managed by NIS receiving excess sedation (NIS+ES group) were also 
compared to preterm lambs managed by NIS without sedation (NIS control group). 
NIS+ES group was defined as preterm lambs managed by NIS that received pentobarbital 
dosage matched to that historically needed by IMV lambs. The contribution of NIS+RN 
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and NIS+ES need to be evaluated to further understand the roles of postnatal nutrition 
and sedation in signaling pathways important to gut integrity. 
 
Study Aims 
Our preliminary data show that preterm lambs managed by IMV have a NEC-like 
phenotype with significant enterocyte damage, and feeding intolerance. However, the 
effects of prematurity, mode of ventilation, postnatal nutrition and sedation on PPARγ, 
FABP2 and occludin expression in the distal ileum remain unknown.  
We hypothesize that in preterm lambs, IMV reduces gut integrity in association 
with decreased ileal expression of PPARγ, FABP2 and occludin.  Furthermore, we 
hypothesize that NIS+RN and NIS+ES will also decrease ileal expression of PPARγ, 



























Figure 1. Histological appearance of terminal ileum of preterm infant without and with 
NEC5 
Intestinal epithelium of the small intestines is made up of villi that consist of microvilli 
projecting from enterocytes. Enterocytes are responsible for absorbing nutrients and 
contain digestive enzymes. Between the villi are pits of crypts. Crypts are responsible for 
the proliferation of intestinal epithelial cells, enterocytes and goblet cells6. Crypt depth is 
defined as the depth of the invagination between adjacent villi. Damage and loss of 
integrity of the intestinal epithelium in NEC (right) is severe compared to preterm infant 
without NEC (left).  In NEC, villi are less in number and deteriorated, and crypt depths 






Table 1. Weight gain of preterm lambs managed by IMV and NIS for 21 days23 
 
 
Preterm lambs managed by NIS gain significantly more weight (mean± SD) than preterm 









                                                     Preterm 21 days  
 NIS IMV 
Weight at delivery (Kg) 4.1 ± 0.9 4.5 ± 0.5 
Weight at end of study (Kg) 4.5 ± 0.4* 3.9 ± 0.4 
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Figure 2. Feeding volume of preterm lambs managed by IMV and NIS over a 21 day 
study period24 
Daily intake in mL/Kg is depicted on the y-axis and day of life on the x-axis. Preterm 
lambs managed by IMV (white circles) consumed significantly less enteral intake 























Figure 3. Histological appearance of distal ileum of preterm lamb managed by NIS and 
IMV for 21 days 
Villi in preterm lambs managed by IMV (right) appear fragmented with greater 




We have extensive experience with our preterm lamb model26, 27, 28. Lambs were 
delivered at 132 ± 2 days; term equivalent age is 150 days gestation. This is comparable 
to 28-37 week gestational age in humans17. Ewes were treated with dexamethasone 
phosphate, ~36  h before operative delivery. All preterm lambs were initially intubated 
and received IMV for the first three hours. Preterm lambs in the IMV group continued 
invasive ventilation method for 3 or 21 days. Preterm lambs in the NIS group were then 
weaned to a high-frequency, flow-interruption ventilator for 3 or 21 days. We chose to 
examine lambs at 3 days to assess acute effects, and 21 days to assess chronic effects.  
The preterm lambs are term-equivalent at 21 days. We also used term-born lambs as a 
comparison group (NL-1d). All lambs received enteral feedings orogastrically. For the 
first 3 days of life, lambs received ewe’s colostrum formula as tolerated (Kid & Lamb 
Colostrum Replacement, Land O Lakes, Arden Hills, MN). At day 4 of life, colostrum 
was replaced with mature ewe’s formula (Sav-A-Lam Milk Products, Chilton, WI). 
Volume of the feedings were gradually increased by 3-5 ml increments, as tolerated, to 
attain a goal of 60-80 kcal/kg/d. Enteral feedings continued in IMV lambs due to 
sedation; however, NIS lambs were able to take milk from a bottle at about 4-5 days of 
life. Feeding intolerance was indicated by residuals in the stomach 30 minutes after each 
feeding. Lambs with apparent gut pathophysiology had an abdominal X-ray for detection 
of gas-filled loops. Feeding and growth data were collected continuously over each 24- 
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hour period.  
Feeding tolerance and weight gain is impacted significantly by the mode of 
ventilation IMV (see Table 1 and Figure 2). In evaluating the components of IMV, 
restricted nutrition and sedation, total calories and weight gain were measured. At 21 
days, NIS+RN preterm lambs had gain significantly less weight than the preterm lambs 
managed by NIS (p≤0.05). Consistent with decreased weight gain, NIS+RN lambs 
received fewer total calories, fluid, protein and fat than NIS.  At 21 days, NIS+ES 
preterm lambs had similar weight gain, as well as total calories, fluid, protein and fat 
intake as preterm lambs managed by NIS26.  
Samples of the last 2 cm of the distal ileum were collected at necropsy at 3 days, 
21 days or 24 hours after term birth, and flash frozen.      
For the purpose of examining different methods of chronic ventilation on NEC-
like phenotype, ileal tissue* samples were analyzed in IMV and NIS lambs at postnatal 3 
day and 21 day, n=5/group, and term lamb (NL-1d), n=4/group. To examine the effect of 
postnatal nutrition and sedation on NEC-like phenotype study groups, NIS+RN and 
NIS+ES were included. Restricted nutrition preterm lambs were managed by NIS for 21 
days and were fed a reduced volume of milk based on the volume (mL/Kg/day) 
historically tolerated by preterm lambs managed by IMV for 21 days (see Figure 2), 
n=4/group. NIS+RN lambs received less total calories, protein and fat than control NIS 
lambs, n=5/group. All preterm lamb groups received pentobarbital (Abbott Laboratories, 
North Chicago, IL) at 1 to 2  mg/Kg, as needed (heart rate >200 beats/min). The NIS and 
NIS+RN groups received pentobarbital at 0.8±0.6 mg/Kg/day. The NIS+ES group 
	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  	  *	  Ileal tissue is examined as NEC largely affects the distal ilium2.	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received pentobarbital at 4.8 mg/Kg/day. This dose is based on daily dosage (mg/Kg/day) 
historically needed to keep preterm lambs supported by IMV comfortable and calm23, 29.  
 
Real-Time PCR 
Real-time reverse transcriptase polymerase chain reaction (RT-PCR) was used to 
analyze mRNA transcript level of FABP2 in the IMV and NIS at 3 days and 21 days and 
term NL-1d. RNA was extracted from ileal tissues and cDNA was generated. GAPDH  
was used as an internal control.  
 
Western Blot 
Protein abundance of PPARγ, FABP2 and occludin was analyzed in all preterm 
lamb study groups (IMV and NIS 3 days and 21 days, NL-1d, NIS+RN and NIS+ES) and 
term reference lambs using Western blot. Lamb ileal tissue samples were homogenized 
and insoluble material and fat were removed by centrifugation. Equal amounts of total 
protein from tissue 10 µg, were loaded into each well on a 10% Bis-Tris Midi Gel, 1.0 
mm x 26 well, and transferred to membrane. Detection of PPARγ protein abundance (58 
kDa) was accomplished by primary antibody PPARγ (1:400 dilution: #sc-7196, Santa 
Cruz) followed by a secondary antibody rabbit IgG (1:8000 dilution #7074S, Cell 
Signaling Technologies). Detection of FABP2 protein abundance (14-15 kDa) was 
accomplished by incubation of membrane with primary antibody FABP2 (1:100 dilution: 
intestinal FABP #PA1-40304, Invitrogen) followed by secondary antibody rabbit IgG 
overnight. Detection of occludin protein abundance (65 kDa) was accomplished by 
primary antibody occludin monoclonal (1:1000 dilution #33-1500, ThermoFisher 
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Scientific) secondary antibody mouse IgG (1:3000 dilution #7076S, Cell Signaling 
Technologies). GAPDH (1:6000 dilution  #2118S, Cell Signaling Technologies) was 
used as an internal control for all antibodies.  
 
Immunofluorescence 
Indirect immunofluorescence was used on ileal tissue sections of preterm lambs 
managed by IMV, NIS, NIS+RN and NIS+ES preterm lambs for 21 days to localize 
FABP2 within the ileum. Primary antibody of intestinal FABP (1:1500 dilution 
#ab60272, Abcam) was applied and incubated overnight. Antibodies were then stained 
with a fluorescein-labeled antibody, SA-AF555 (1:500 dilution).   
 
Statistical Analysis 
Based on our experience, sample sizes of 4-6 are sufficient to determine 
significant differences between preterm lambs managed by IMV, NIS and NIS+RN and 
NIS+ES24, 25, 26. All results are expressed as mean ± standard deviation (SD). Statistical 
comparisons for mRNA and protein abundance between groups are made using ANOVA 
analysis, with fishers least squared post hoc test using Statview 5 software package (SAS 
Institute, Inc.). A statistically significant difference between groups is determined with a 




PPARγ Protein Abundance 
Based on of the importance of PPARγ to epithelial cell integrity, we measured 
PPARγ protein abundance. Figure 4 shows PPARγ abundance is less in preterm lambs 
managed by IMV for 3 days, compared to preterm lambs managed by NIS (p≤0.05). In 
addition, immunohistochemistry staining of the distal ileum demonstrates that PPARγ 
localizes to the villi of preterm lambs, and appears less in preterm lambs managed by 
IMV compared to preterm labs managed by NIS (see Figure 5).  
PPARγ protein abundance was also evaluated in preterm lambs managed by IMV 
and NIS for 21 days (see Figure 6). Preterm lambs managed by IMV for 21 days had 
significant reduction in ileal PPARγ protein abundance compared to preterm lambs 
managed by NIS (p≤0.05). Preterm lambs managed by NIS+RN had significantly less 
PPARγ protein abundance compared to preterm lambs managed by NIS (see Figure 6; 
p≤0.05). PPARγ protein abundance in NIS+RN was similar to PPARγ protein abundance 
in preterm lambs managed by IMV for 21 days (p=0.626). PPARγ protein abundance of 
preterm lambs managed by NIS+ES was less than preterm lambs managed by NIS, 
although not statistically significant (see Figure 6; p=0.092). There was no statistically 





 FABP2 was measured due to its role in the activation of PPARγ, as well as being 
a transcriptional target of PPARγ. To understand the effects on FABP2 transcription, 
FABP2 mRNA was measured in the distal ileum of preterm lambs managed by IMV and 
NIS for 3 days and 21 days and term lambs. FABP2 mRNA was significantly less in 
preterm lambs managed by IMV for 3 days and 21 days compared to preterm lambs 
managed by NIS for 3 days and 21 days (see Figure 7 and 8; p≤0.05). Preterm lambs 
managed by IMV had decreased FABP2 mRNA levels compared to term lambs (p≤0.05). 
However, preterm lambs managed by NIS did not significantly alter FABP2 mRNA 
levels compared to term lambs (p=0.36). 
 To understand the functional effects, FABP2 protein abundance was also 
measured in all groups. Preterm lambs managed by IMV for 3 days had reduced FABP2 
protein abundance compared to preterm lambs managed by NIS for 3 days (see Figure 7; 
p≤0.001). FABP2 protein abundance in preterm lambs managed IMV remained 
significantly less compared to preterm lambs managed by NIS for 21 days (see Figure 8; 
p≤0.05). However, by 21 days, the reduction in FABP2 protein abundance in preterm 
lambs managed by IMV was not statistically significant compared to term lambs 
(p=0.103).  
Postnatal nutrition had a significant impact on FABP2 protein abundance (see 
Figure 9). Preterm lambs managed by NIS+RN for 21 days have a significant reduction 
in FABP2 protein abundance compared to preterm lambs managed by NIS for 21 days 
(p≤0.05). In fact, preterm lambs managed by NIS+RN had similar FABP2 protein 
abundance as preterm lambs managed by IMV for 21 days (p=0.702). Despite similar 
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postnatal growth, as preterm lambs managed by NIS for 21 days, preterm lambs managed 
by NIS+ES had significantly less FABP2 protein abundance than NIS managed preterm 
lambs (p≤0.05). Preterm lambs managed by NIS+ES had similar FABP2 protein 
abundance as preterm lambs managed by IMV for 21 days (p=0.73). 
 
Occludin Protein Abundance 
Occludin, a transcriptional target of PPARγ, is important for maintaining tight 
junction function. In contrast to FABP2 protein abundance, preterm lambs managed by 
IMV for 3 days had greater occludin protein abundance compared to preterm lambs 
managed by NIS for 3 days (see Figure 10; p<0.05).  
At 21 days, there was no statistical significant difference between preterm lambs 
managed by IMV, NIS+RN or NIS+ES and preterm lambs managed by NIS (see Figure 
11). Additionally, there was no significant difference between any preterm lamb groups 
and term lambs.  
 
FABP2 Localization Immunofluorescence 
Immunofluorescence images of the distal ileum of preterm lambs, managed for 
21days by IMV, NIS, NIS+RN and NIS+ES (see Figure 12), show localization of FABP2 
in the cytoplasm of the enterocytes. NIS appears to have greater localization of FABP2 in 
the enterocytes compared to IMV. Additionally, it appears that the villus morphology is 
impacted in preterm lambs managed by IMV. Villi appear to be fragmented, shorter in 
length and less in abundant compared to NIS. Preterm lambs managed by NIS+RN 
appear to have similar localization of FABP2 and villi morphology as preterm lambs 
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managed by IMV. In contrast, preterm lambs managed by NIS+ES appear to have greater 
localization of FABP2 and the morphology of the villi appear less injured compared to 
preterm lambs managed by IMV.  
Figure 4. PPARγ protein abundance preterm lambs managed by IMV and NIS for 3 days	  
Preterm lambs managed by IMV for 3 days have a significantly reduced ileal PPARγ 
















Figure 5. Immunohistochemistry localization of PPARγ in villi of preterm lambs 
managed by NIS and IMV for 3 days  
PPARγ is shown in white. PPARγ appears to be less in the distal ileum of preterm lambs 





Figure 6. PPARγ protein abundance in distal ileal tissue in term lambs and preterm lambs 
managed by IMV, NIS, NIS+RN and NIS+ES for 21 days 
Preterm lambs managed by IMV and NIS+RN have significantly less PPARγ protein 








Figure 7. FABP2 mRNA and protein abundance in distal ileal tissue of preterm lambs 
managed by IMV compared to NIS preterm lambs for 3 days 
FABP2 mRNA and protein abundance in preterm lambs managed by IMV for 3 days is 
significantly lower compared to preterm lambs managed by NIS for 3 days (n=3-5/group; 


















Figure 8. FABP2 mRNA in distal ileal tissue of preterm lambs managed by IMV 
compared to NIS preterm lambs for 21 days 
FABP2 mRNA and protein abundance in preterm lambs managed by IMV for 21 days is 
significantly lower compared to preterm lambs managed by NIS for 21 days (n=3-
5/group; *p < 0.05).  
 
 
Figure 9. FABP2 protein abundance in distal ileal tissue in term lambs and preterm lambs 
managed by IMV, NIS, NIS+RN and NIS+ES for 21 days 
Preterm lambs managed by IMV, NIS+RN and NIS+ES for 21 days have a significant 
reduction in FABP2 protein abundance than preterm lambs managed by NIS for 21 days 
















Figure 10. Occludin protein abundance in distal ileal tissue in preterm lambs managed by 
IMV and NIS for 3 days  
Preterm lambs managed by IMV for 3 days had significantly more ileal occludin protein 







Figure 11. Occludin protein abundance in distal ileal tissue in term lambs and preterm 
lambs managed by IMV, NIS, NIS+RN and NIS+ES for 21 days 
There was no significant difference in occludin protein abundance between groups. 





Figure 12. Localization of FABP2 in distal ileum of preterm lambs managed by NIS, 
IMV, NIS+RN and NIS+ES for 21 days 
All images are at the same magnification. Red stain is FABP2. Immunofluorescence was 
not used for quantification in this stage of the experiment. Order of images: NIS (A), 
IMV (B), NIS+RN (C) and NIS+ES (D). 
A	   B	  




Understanding molecular mechanisms of gut integrity in response to prematurity 
and mode of ventilation is important to understanding the pathogenesis of NEC. The 
evaluation of preterm lambs managed by IMV and NIS for 3 days and 21 days supports a 
more invasive form of ventilation and significantly alters the mucosal barrier morphology 
as well as PPARγ and FABP2 expression, also important to gut integrity. Decreased 
expression of PPARγ and FABP2 may indicate an interruption in the PPARγ-FABP2 
signaling pathway, and subsequent disruption of gut integrity. Contrary to our hypothesis, 
neither IMV nor NIS effected occludin expression. These data suggest that occludin-
regulated mucosal barrier function is not a mechanism by which IMV and postnatal 
nutrition give rise to a NEC-like phenotype. 
In preterm lambs managed by NIS, restricted nutrition decreased weight gain, 
altered villi morphology and PPARγ and FABP2 expression similar to preterm lambs 
managed by IMV. However, preterm lambs managed by NIS plus excessive sedation did 
not alter villi morphology or have a significant impairment of the PPARγ and FABP2 
expression compared to preterm lambs managed by IMV. Occludin protein abundance 
was not impacted by mode of ventilation and does not appear to be associated with 
PPARγ expression.  
In epidemiological studies, prematurity is the only factor to be a consistent 
independent determinant of NEC30. Intestinal immaturity is characterized by immature 
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motility, digestion, absorption, immune defenses and barrier function3. However, non-
ventilated term born lambs did not differ significantly in PPARγ protein abundance, 
FABP2 expression or occludin protein abundance compared to any of our premature 
ventilated IMV groups or NIS groups. Within the term lambs selected for this study, 
protein abundance measurements had large variability. This variability likely reflects 
healthy biological variability.  
We hypothesized PPARγ protein abundance would be reduced with 
gastrointestinal injury seen in preterm lambs managed by IMV. PPARγ protein 
abundance was reduced both at 3 days and 21 days in preterm lambs managed by IMV. 
Our observation of reduced PPARγ abundance in preterm lambs managed by IMV is 
consistent with other animal models of induced intestinal damage11. Our lab has 
previously shown that preterm lambs managed by NIS+RN had significant damage to 
lung formation and reduced lung PPARγ protein abundance relative to that seen in IMV 
lambs26. Our study found PPARγ protein abundance to be reduced in preterm lambs 
managed by NIS+RN for 21 days. This decrease in PPARγ activity in the lung and in the 
distal ileum suggests a decrease in availability of a PPARγ agonist.  
An important agonist for PPARγ is the long chain polyunsaturated fatty acid, 
DHA. Restricted feeding, secondary to prematurity, is linked to marked differences in 
available essential fatty acids in preterm neonate31, 32. In our lamb model, preterm lambs 
managed by IMV for 21 days have altered circulating fatty acid profiles compared to 
term born lambs33. Our results suggest that feeding intolerance in preterm lambs managed 
by IMV and caloric restriction in NIS+RN limits fatty acid substrate availability and thus 
reduces PPARγ activity.  
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Limited PPARγ activity results in a decrease expression and activity of its 
downstream target FABP2. FABP2 was decreased both at the transcriptional level and at 
the protein level in both preterm lambs managed by IMV and preterm lambs managed by 
NIS+RN. The reduction of FABP2 expression is supported by the appearance of a 
reduced localization of FABP2 in the enterocytes of preterm lambs managed by IMV and 
NIS+RN compared to NIS at 21 days. A reduction of FABP2 reduces the shuttle of fatty 
acids to the nucleus, subsequently inactivating PPARγ and interfering with the PPARγ-
FABP2 feedback loop. The reduction of both PPARγ protein abundance and FABP2 
expression supports the protective relationship PPARγ and FABP2 have on gut integrity.  
Based on animal10 and human21 studies of NEC, we hypothesized that occludin 
protein abundance would also be reduced by a decrease in PPARγ activity. In contrast to 
PPARγ protein abundance and FABP2 expression, occludin protein abundance was 
greater in preterm lambs managed by IMV for 3 days compared to preterm lambs 
managed by NIS. Based on greater PPARγ levels in preterm lambs managed by NIS at 21 
days, we expected a biological priority of PPARγ would be to promote the transcription 
of occludin to mediate the paracellular permeability common in prematurity. Introduction 
of PPARγ agonist has been shown to reduce permeability and tighten the junction 
function34. Protein abundance may not be the appropriate assessment of occludin 
transcription. Occludin functions in tight junctions with claudin to form the sealing 
element21 and may be bound too tightly for protein to be assessed. Occludin mRNA has 
been shown to be markedly decreased in NEC tissue in neonates21. Occludin mRNA 
should be assessed in our lamb model to confirm or elucidate our protein results. 
We hypothesized excessive sedation would have a significant impact on gut 
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integrity as sedation affects gastrointestinal motility, absorption and blood flow35-38. 
Preterm lambs managed by NIS+ES had caloric intake and growth similar to preterm 
lambs managed by NIS. PPARγ protein abundance was not significant reduced in 
preterm lambs managed by NIS+ES compared to NIS. The minimal reduction in PPARγ 
protein abundance could be attributed to feeding tolerability and an increase in fatty acid 
substrate availability. However, FABP2 protein abundance was significantly altered in 
preterm lambs managed by NIS+ES compared to preterm lambs managed by NIS. In 
contrast, occludin protein abundance appears to be greater in NIS+ES than preterm lambs 
managed by NIS. A biological advantage in preterm lambs managed by NIS+ES to 
promoting the transcription of occludin would be to decrease paracellular permeability. 
Sedation interference with motility, coupled with increase permeability, would increase 
the risk bacteria translocation, resulting in systemic inflammatory responses and sepsis2.  
Our data suggest that PPARγ and FABP2 may be affected by altered circulating 
fatty acids due to restricted nutrition. In preterm neonates, change in long-chain fatty acid 
levels during the first postnatal month is linked to comorbidities such as chronic lung 
disease and late-onset sepsis in human neonates31. However, clinical trails of long-chain 
polyunsaturated fatty acid supplementation for NEC in preterm neonates have not shown 
a reduction in NEC32.  These studies were not looking at NEC as the primary outcome 
measure and lacked power32. Continuing research in our lab is being conducted on DHA 
supplementation in preterm lambs managed by IMV and NIS+RN to validate that poor 
postnatal nutrition secondary to prematurity is a causal factor involved in the regulation 
of the PPARγ and FABP2 expression and poor gut integrity. Currently, our lab has a pilot 
experiment to examine the effects of daily DHA supplementation of 150 mg/kg/d on the 
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development of NEC-like phenotype, preterm lambs managed by IMV for 21 days.  
Our preterm lamb model is unique in that damage to the intestines is due to 
natural responses to prematurity, mode of ventilation and poor postnatal nutrition. Most 
animal models are designed to examine the molecular mechanisms of NEC by induced 
damage via hypoxia-ischemia or formula feeding. These methods may not accurately 
recapitulate the nature of human NEC. A limitation to our study is a small sample size. 
Sample size is limited due to the high cost of generating and managing the preterm 
lambs, particularly for the 21 days studies. Our experiments were also not powered to 
determine differences in outcome between male and female preterm lambs for any 
interventions. Additionally, inflammation is a factor in the development of NEC and in 
our research, we have not evaluated inflammatory markers in any lamb groups at this 
time. A further limitation of our study is that it is descriptive. We have not assessed 
cause-and-effect relationships between PPARγ signaling and gut integrity.   
The morbidity and mortality rate of NEC remains unchanged, largely because of 
the lack of understanding of pathogenic pathways and protective measures. Elucidating 
the molecular mechanism of PPARγ protection on intestinal integrity through interactions 
with FABP2 will provide support for PPARγ-pathway activation as a targeted 
therapeutic. If supplementation of DHA in preterm lambs managed by IMV and NIS+RN 
improve feeding tolerance and gut integrity, marked by increased PPARγ and FABP2 
expression, it would support early introduction of PPARγ agonist as a protective and a 
preventative treatment for NEC. 
In conclusion, our results demonstrated that IMV, NIS+RN and NIS+ES decrease 
PPARγ and FABP2 expression in the preterm lamb ileum. Disruption to PPARγ and 
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FABP2 expression by IMV and inadequate nutrition likely has detrimental effects on gut 
integrity and may contribute to a NEC-like phenotype. Further research on occludin 
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